UK firms endorse global register

UK drugs firms have lauded plans to set up a global register of clinical trials on new prescription-only medicines as ‘a major step towards achieving greater transparency’.

The Association of the British Pharmaceutical Industry (ABPI) last week endorsed proposals – drawn up by the world’s top pharma trade associations, such as US body PhRMA, and agreed by major companies – saying they had the ‘full endorsement’ of the UK industry.

Rather than placing information on a single website, the industry will ensure all sites are linked as some companies – such as GlaxoSmithKline and Eli Lilly – have already created their own sites.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.